Efficacy of Rho-kinase inhibitor ophthalmic solution on bleb formation after trabeculectomy, a randomized parallel study
Not Applicable
- Conditions
- Open angle glaucoma
- Registration Number
- JPRN-UMIN000019017
- Lead Sponsor
- Department of Ophthalmology, Hiroshima University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 122
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients who had intraocular surgeries within six months. 2) Patients whose intraocular pressure are not able to be measured by Goldmann applanation tonometer. 3) Patients who had conjunctival surgeries (including glaucoma surgeries). 4) Patients who have an allergy to the ingredients of Rho-kinase inhibitor ophthalmic solution. 5) Patients who used Rho-kinase inhibitor ophthalmic solution before surgery. 6) Patients under the pregnancy or nursing. 7) Patients who are determined as an unsuitable person for this study by the doctor.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Transition of intraocular pressure for twelve months after surgery Bleb scoring at six months after surgery
- Secondary Outcome Measures
Name Time Method